TD Waterhouse Canada’s Nautilus Biotechnolgy NAUT Stock Holding History

TD Waterhouse Canada’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.3K	Buy	16,000 +15,000	+1,500%	+$39.6K	﹤0.01%	1563
2026 Q1	$3.35K	Hold	1,000	–	–	﹤0.01%	1984
2025 Q4	$1.93K	Hold	1,000	–	–	﹤0.01%	1823
2025 Q3	$830	Hold	1,000	–	–	﹤0.01%	1908
2025 Q2	$734	Hold	1,000	–	–	﹤0.01%	1830
2025 Q1	$831	Hold	1,000	–	–	﹤0.01%	1762
2024 Q4	$1.67K	Hold	1,000	–	–	﹤0.01%	1725
2024 Q3	$2.7K	Hold	1,000	–	–	﹤0.01%	1594
2024 Q2	$2.26K	Hold	1,000	–	–	﹤0.01%	1627
2024 Q1	$2.69K	Hold	1,000	–	–	﹤0.01%	1632
2023 Q4	$3.02K	Hold	1,000	–	–	﹤0.01%	1445
2023 Q3	$2.94K	Hold	1,000	–	–	﹤0.01%	1448
2023 Q2	$3.87K	Hold	1,000	–	–	﹤0.01%	1435
2023 Q1	$2.75K	Hold	1,000	–	–	﹤0.01%	1476
2022 Q4	$1.68K	Hold	1,000	–	–	﹤0.01%	1504
2022 Q3	$2.14K	Hold	1,000	–	–	﹤0.01%	1499
2022 Q2	$2.66K	Hold	1,000	–	–	﹤0.01%	1504
2022 Q1	$4.5K	Hold	1,000	–	–	﹤0.01%	1467
2021 Q4	$5.07K	Buy	+1,000	New	+$5.35K	﹤0.01%	1456

Other funds holding NAUT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return

Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TD Waterhouse Canada's NAUT Position: Q2 2026 in Review

TD Waterhouse Canada increased its Nautilus Biotechnolgy (NAUT) stake by 1,500% in Q2 2026, buying an estimated $39.6K and bringing the position to 16,000 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

TD Waterhouse Canada first reported a position in NAUT in Q4 2021 and has held it in 19 quarters since. 31 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

TD Waterhouse Canada held 16,000 shares of Nautilus Biotechnolgy worth $29.3K as of Q2 2026.
TD Waterhouse Canada bought 15,000 Nautilus Biotechnolgy shares in Q2 2026, an estimated $39.6K.
Nautilus Biotechnolgy made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1563 holding.
TD Waterhouse Canada first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 19 quarters since.
31 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.